However, the expression of GPx1 has been reported to be down-regulated in thyroid cancer [44], colorectal cancer [45, 46], and gastric cancer [47], whereas GPx1 has been demonstrated to play an oncogenic role in kidney cancer [48], pancreatic cancer [49], and laryngeal squamous cell carcinoma [50]
Zhu Y, Wu Z, Yan W, et al
The driver may be mast-cell-mediated or systemic rather than NF-B-local, and if so, increasing the dose for additional KPV will not address it see the mast-cell note under Phenotype Considerations
KPV: Immune Modulation and Inflammation Control KPV is a tripeptide derived from -melanocyte-stimulating hormone (-MSH)
California Infusion Centers offers: For patients comparing providers, trust matters just as much as convenience
Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells